SUR
$250.00
Out of stock
* The information on this page is a summary and is not intended to cover all available information about this medication. It does not cover all possible uses, directions, precautions, drug interactions or adverse effects and is not a substitute for the expertise and judgement of your healthcare professional.
Survodutide (BI 456906) 10mg*10vials 250$
• Chemical Name: Glucagon and GLP-1 receptor dual agonist
• Molecular Formula: C₄₁H₅₄N₁₀O₈
Mechanism of Action
• Dual Agonism: Survodutide is a dual agonist of the glucagon and glucagon-like peptide-1 (GLP-1) receptors. It is derived from glucagon and administered once weekly via subcutaneous injection.
• Weight Loss: By activating both the glucagon and GLP-1 receptors, Survodutide enhances weight loss through increased energy expenditure and reduced food intake. The glucagon receptor activation stimulates gluconeogenesis, glycogenolysis, and lipolysis, while GLP-1 receptor activation delays gastric emptying and reduces appetite.
• Metabolic Benefits: Survodutide also improves glucose tolerance by stimulating insulin secretion and reducing hepatic fat content, which is particularly beneficial in conditions like non-alcoholic steatohepatitis (NASH).
Reviews
Clear filtersThere are no reviews yet.